The Insanity of the PCR Testing Saga

19 February 2021 — Mercola

Analysis by Dr. Joseph Mercola Fact Checked

Story at-a-glance

  • Curative offers a PCR test using spit rather than swabs from the back of your nasal cavity. Initially only authorized for use on symptomatic patients, the company has requested the U.S. Food and Drug Administration expand its authorization for use on asymptomatic individuals
  • According to company data, the spit test accurately identifies about 90% of positive cases when compared against a nasopharyngeal PCR test set to 35 CT
  • According to the FDA, that comparative CT is too low, and will produce too many false negatives. This, despite the scientific consensus, which states anything over 35 CTs is scientifically unjustifiable as it produces enormous amounts of false positives
  • According to an April 2020 study, a CT of 17 must be used to obtain 100% confirmed real positives. Above 17 cycles, accuracy drops dramatically. At 33 cycles, the false positive rate is 80%. Beyond 34 cycles, the false positive rate reaches 100%
  • Because the PCR test cannot discern between live virus and dead, noninfectious viral debris, the timing of the test is important. Recent research shows the median time from symptom onset to viral clearance confirmed by viral culture is seven days, whereas the PCR test continues to detect nonviable (noninfectious) SARS-CoV-2 for a median of 34 days

RT-PCR Test to Detect SARS-CoV-2 Reveals 10 Major Scientific Flaws at the Molecular and Methodological Level:

1 December 2020 — Global Research

Consequences for False Positive Results

External Peer Review

By Pieter Borger, Bobby Rajesh Malhotra, and et al.

Corman-Drosten Review Report 27 November 2020

Abstract

In the publication entitled “Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR” (Eurosurveillance 25(8) 2020) the authors present a diagnostic workflow and RT-qPCR protocol for detection and diagnostics of 2019-nCoV (now known as SARS-CoV-2), which they claim to be validated, as well as being a robust diagnostic methodology for use in public-health laboratory settings.

Continue reading